Comparative Adverse Drug Profile of Deflazacort Vs Conventional Corticosteroids in Spontaneous Reporting System of Pharmacovigilance.

Simple item page
dc.contributor.authorTandon, Vishal R
dc.contributor.authorSingh, Pritpal
dc.contributor.authorMahajan, Annil
dc.contributor.authorKhajuria, Vijay
dc.contributor.authorMahajan, Vivek
dc.date.accessioned2016-02-11T03:33:37Z
dc.date.available2016-02-11T03:33:37Z
dc.date.issued2014-01
dc.description.abstractThe current observational cross-sectional study was undertaken using suspected adverse drug data collection form available under (PvPI) to evaluate comparative ADR profile of DFZ Vs CCS for 3 years in spontaneous reporting system of ADRs in current PvPI. Total number of ADR reports during the study period was 3024, out of which ADRs reports due to CS were 112 accounting for a rate of 3.70%. The rate of total ADR events with CS was 4.11%. Geriatric, urban and female population predominated in contributing ADRs with both CCS and DFZ in the study. Self medication of CCS and DFZ contributed 10.95% and 7.69% of total ADRs. Oral route contributed maximal ADRs. Irrational drug prescription contributed substantially. Maximum ADRs due to CCS and DFZ were moderate, latent, non-serious, type A and were probable followed by possible in nature as per WHO UMC scale. Gastritis, new onset hypertension/ loss of hypertensive control, loss of diabetic control, obesity/overweight, dyslipedemia were common ADRs. Thus, ADRs due to CS is a substantial health problem. ADR profile did not vary although DFZ recorded less ADRs.en_US
dc.identifier.citationTandon Vishal R, Singh Pritpal, Mahajan Annil, Khajuria Vijay, Mahajan Vivek. Comparative Adverse Drug Profile of Deflazacort Vs Conventional Corticosteroids in Spontaneous Reporting System of Pharmacovigilance. JK Science Journal of Medical Education and Research. 2014 Jan-Mar; 16(1): 16-20.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/172376
dc.language.isoenen_US
dc.source.urihttps://www.jkscience.org/archives/volume161/original_article3.pdfen_US
dc.subjectAdverse Drug Reactionen_US
dc.subjectDeflazacorten_US
dc.subjectCorticosteroidsen_US
dc.subjectPharmacovigilanceen_US
dc.titleComparative Adverse Drug Profile of Deflazacort Vs Conventional Corticosteroids in Spontaneous Reporting System of Pharmacovigilance.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
jksjmer2014v16n1p16.pdf
Size:
153.87 KB
Format:
Adobe Portable Document Format
Description:
Original Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
JK Science Journal of Medical Education and Research